Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025
Amphastar Announces FDA Approval for Ipratropium Bromide HFA
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
Amphastar Announces FDA Approval for Teriparatide Injection
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference